Rapid Marburg antigen screening for outbreak-response programs.
GoldN™ Easy to Use Marburg Rapid Antigen Test is a rapid antigen screening assay for public-health, outbreak-response, and institutional evaluation where timely Marburg virus disease screening is needed.
Not a U.S. consumer product. Not sold on areyougoldn.com.
Marburg virus antigen screening for program deployment.
GoldN™ Easy to Use Marburg Rapid Antigen Test supports outbreak-response and institutional programs that need a practical antigen screen outside traditional central-lab workflows.
Marburg virus antigen
Built as a Marburg-focused rapid antigen screen for program and outbreak-response evaluation.
Antigen screening framed for Marburg virus disease programs.
Healthcare workers, NGOs, and authorized organizations.
Clinical, outbreak-response, and limited-infrastructure sites.
Antigen presence or absence with a control-line check.
A negative result does not rule out Marburg virus disease.
Built for simple, decentralized screening.
The workflow prioritizes minimal training burden and clear visual interpretation for program deployment.
Collect the blood sample
Obtain the fingerstick blood sample per program protocol and instructions.
Run the assay
Apply sample and buffer to the test cassette according to instructions.
Wait for development
Allow the strip to develop the control and test line pattern.
Read the result
Interpret the visual qualitative result. Confirmatory clinical assessment remains available when symptoms persist.
Marburg focus. Outbreak settings. Clear visual readout.
Built for Marburg screening programs that need operational simplicity in outbreak-response and limited-infrastructure settings.
Marburg-focused screen
Built as a Marburg virus antigen screening assay for program evaluation.
Outbreak-response settings
Supports decentralized and limited-infrastructure screening workflows.
Program audiences
Healthcare workers, NGOs, and institutional buyers.
Companion path
GoldN Companion is in development for connected workflows.
Where Marburg antigen screening fits operationally.
Category comparison for procurement and program design discussions. Not a performance league table.
| Metric | GoldN™ Easy to Use Marburg Rapid Antigen Test | Typical filovirus blood RDT |
|---|---|---|
| Pathogen focus | Marburg virus antigen screen | Varies by filovirus assay |
| Sample | Fingerstick blood | Capillary or venous blood (typical) |
| Setting emphasis | Outbreak-response / field / institutional | Clinic and outbreak (varies by product) |
| Result type | Visual qualitative screen | Visual qualitative screen (typical) |
| Primary users | Program staff and authorized organizations | Clinicians and response teams |
| U.S. consumer retail | No | Varies; this GoldN program is not sold as a U.S. consumer product |
Pathogen focus
Sample
Setting emphasis
Result type
Primary users
U.S. consumer retail
GoldN Companion for connected screening programs.
GoldN™ Easy to Use Marburg Rapid Antigen Test is a visual assay for program use. GoldN Companion is in development for connected workflows.
- This assay is not a U.S. consumer product.
- GoldN Companion is in development and not available for sale.
- Not cleared or approved by the FDA.
GoldN Companion video
The video shows the companion concept and the workflow direction for connected screening programs.
NOVODX works with public-health programs and distributors.
Governments, NGOs, and authorized organizations can request program information, evaluation supply, and procurement discussions.
Contact NOVODXPublic-health screening outside the U.S. consumer market.
This chapter is a public-health program page. It is not a U.S. consumer product and is not sold on areyougoldn.com.
Program questions in plain clinical language.
What does the test screen for?
The assay is designed to screen for Marburg virus antigen as part of Marburg virus disease response and program evaluation workflows.
What sample type does the test use?
The test uses a fingerstick blood sample for rapid antigen screening workflows.
Who is the intended user?
Healthcare workers, public health programs, NGOs, and authorized organizations conducting Marburg screening activities.
Where can the test be used?
Clinical, outbreak-response, and field settings, including areas with limited laboratory infrastructure.
How are results interpreted?
The test provides a visual result indicating the presence or absence of Marburg virus antigen. A control line confirms proper test function. Results are qualitative and intended for screening purposes.
Does a negative result rule out Marburg virus disease?
No. A negative result does not definitively rule out Marburg virus disease. If symptoms persist, further clinical assessment and confirmatory testing are recommended.
How can organizations request pricing or bulk supply?
Governments, NGOs, and distributors may request pricing and availability by contacting NOVODX through this website.